Grants per year
Personal profile
Research Interests
Inflammatory bowel disease (Crohn's disease and ulcerative colitis), therapeutic drug monitoring, clinical trials
Training Experience
| 2011 | Residency, Boston University Medical Center |
| 2014 | Fellowship, University of Chicago |
| 2015 | Fellowship, Northwestern University, Feinberg School of Medicine |
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
Medicine, MD, Federal University of Ceara, Brazil
… → 2006
Research interests keywords
- Inflammatory Bowel Disease
Fingerprint
Dive into the research topics where Emanuelle Araujo Lima Bellaguarda is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Prot #Vedolizumab-4033: ENTYVIO(R) Long-Term Real-World Outcomes in Bio-naïve Ulcerative Colitis and Crohn's Disease Patients in Canada and the US: An EVOLVE Observational Follow-up Study
Bellaguarda, E. A. L. (PD/PI)
PPD Investigator Services, LLC, Takeda Development Center Americas, Inc.
11/1/22 → 11/1/25
Project: Research project
-
Prot#TAK-018-2001: A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase 2a Study to Evaluate the Safety, Tolerability, and Early Proof of Concept of TAK-018 for the Prevention of Postoperative Crohn's Disease Recurrence
Bellaguarda, E. A. L. (PD/PI)
Pharmaceutical Research Associates, Inc., Millennium Pharmaceuticals, Inc.
12/17/21 → 12/17/24
Project: Research project
-
Prot# Cx601-0303: A phase III, randomized, double blind, parallel group, placebo controlled, international, multicentre study to assess efficacy and safety of Cx601, adult allogeneic expanded adipose-derived stem cells (eASC), for the treatment of complex
Bellaguarda, E. A. L. (PD/PI) & Hanauer, S. B. (Other)
7/30/21 → 7/30/24
Project: Research project
-
Validation of a Machine Learning Algorithm to Assess Colonoscopic Disease Activity in Inflammatory Bowel Disease
Bellaguarda, E. A. L. (PD/PI) & Keswani, R. N. (PD/PI)
Virgo Surgical Video Solutions, Inc
6/15/21 → 10/31/22
Project: Research project
-
Prot#M14-533: A Phase 3 multicenter, open-label extension (OLE) study to evaluate the long-term safety and efficacy of ABT-494 in subjects with ulcerative colitis (UC)
Bellaguarda, E. A. L. (PD/PI)
7/29/20 → 7/29/23
Project: Research project
-
Tofacitinib Does Not Impair Sperm Quality in Men With Ulcerative Colitis
Grosen, A., Bellaguarda, E., Liljeqvist-Soltic, I., Skytte, A. B., Hanauer, S. B. & Kelsen, J., Mar 1 2025, In: Inflammatory bowel diseases. 31, 3, p. 882-884 3 p.Research output: Contribution to journal › Article › peer-review
-
Humoral immune response and safety of SARS-CoV-2 vaccination in very early onset inflammatory bowel disease
Kastl, A. J., Weaver, K., Zhang, X., Strople, J., Adler, J., Kelsen, J., Dubinsky, M., Bousvaros, A., Watkins, R., Dai, C., Cross, R., Higgins, P. R., Ungaro, R., Bewtra, M., Bellaguarda, E. A., Farraye, F. A., Chun, K., Zikry, M., Bastidas, M. & Boccieri, M. & 3 others, , Apr 2024, In: Journal of pediatric gastroenterology and nutrition. 78, 4, p. 871-877 7 p.Research output: Contribution to journal › Article › peer-review
-
Long-Term Effectiveness and Durability of COVID-19 Vaccination Among Patients With Inflammatory Bowel Disease
Brenner, E. J., Weaver, K. N., Zhang, X., Kastl, A. J., Strople, J. A., Adler, J., Dubinsky, M. C., Bousvaros, A., Watkins, R., Dai, X., Chen, W., Cross, R. K., Higgins, P. D. R., Ungaro, R. C., Bewtra, M., Bellaguarda, E. A., Farraye, F. A., Chun, K. Y., Zikry, M. & Bastidas, M. & 5 others, , Jul 2024, In: Clinical Gastroenterology and Hepatology. 22, 7, p. 1475-1486.e4Research output: Contribution to journal › Article › peer-review
3 Scopus citations -
Humoral Immune Response and Safety of SARS-CoV-2 Vaccination in Pediatric Inflammatory Bowel Disease
Kastl, A. J., Weaver, K. N., Zhang, X., Strople, J. A., Adler, J., Dubinsky, M. C., Bousvaros, A., Watkins, R., Dai, X., Chen, W., Cross, R. K., Higgins, P. D. R., Ungaro, R. C., Bewtra, M., Bellaguarda, E. A., Farraye, F. A., Chun, K. Y., Zikry, M., Fernando, M. & Bastidas, M. & 6 others, , Jan 1 2023, In: American Journal of Gastroenterology. 118, 1, p. 129-137 9 p.Research output: Contribution to journal › Article › peer-review
Open Access9 Scopus citations -
Low Rates of Breakthrough COVID-19 Infection after SARS-CoV-2 Vaccination in Patients with Inflammatory Bowel Disease
Weaver, K. N., Zhang, X., Dai, X., Chen, W., Watkins, R., Adler, J., Dubinsky, M. C., Kastl, A., Bousvaros, A., Strople, J. A., Cross, R. K., Higgins, P. D. R., Ungaro, R. C., Bewtra, M., Bellaguarda, E., Farraye, F. A., Craig, R. B., Hernandez, C., Boccieri, M. E. & Firestine, A. & 3 others, , Mar 1 2023, In: Inflammatory bowel diseases. 29, 3, p. 483-486 4 p.Research output: Contribution to journal › Article › peer-review
Open Access7 Scopus citations